Boston Scientific Corporation (NYSE: BSX), Minneapolis, MN – FDA Inspections
Inspection records and compliance data for Boston Scientific Corporation in Minneapolis, Minnesota. 6 FDA inspections on record, last inspected February 24, 2016. Publicly traded as NYSE: BSX.
This profile covers Boston Scientific Corporation based in Minneapolis, Minnesota, United States.
FDA Inspection History
- FDA inspections
- 6
- OAI
- 0
- VAI
- 0
- NAI
- 6
- Form 483s
- 0
- Warning letters
- 0
First inspected May 18, 2009. Last inspected February 24, 2016.
FDA inspections (6)
| Date | Result | FDA center(s) | Insp. # |
|---|---|---|---|
| February 24, 2016 | NAI | Medical Devices & Rad Health · Compliance: Devices | 973827 |
| December 28, 2012 | NAI | Medical Devices & Rad Health · Postmarket Assurance: Devices | 812245 |
| October 4, 2012 | NAI | Medical Devices & Rad Health · Compliance: Devices | 803670 |
| January 24, 2011 | NAI | Medical Devices & Rad Health · Postmarket Assurance: Devices | 707222 |
| January 21, 2010 | NAI | Medical Devices & Rad Health · Compliance: Devices | 639194 |
| May 18, 2009 | NAI | Medical Devices & Rad Health · Compliance: Devices | 583272 |
No Form 483s, Warning Letters or EIRs on record.
Companies with similar regulatory profiles, compliance history, and operations.
Name
Boston Scientific Corporation
Stock ticker
BSX
Exchange
NYSE
Share price
$44.61
Market cap
$64.7B
Price as of
November 6, 2026
FEI Number
2183460
Address
9055 Evergreen Blvd NW, Minneapolis, Minnesota 55433, United States
Country
United States
ID: 915c6dba-4029-4f22-8499-a12417a2bd08